glp-1 stall Ozempic Plateau: Why Weight Loss Drugs May Stop Working GLP-1 Plateau: Causes & Solutions

The WHO endorsement could strengthen the case for provincial drug plan coverage of both brand-name and upcoming generic GLP-1 medications

May be given into a vein by IV May be given as a tablet by mouth May be given as a liquid by mouth Diarrhea Nausea Vomiting Upset stomach Abdominal (belly) pain Body odor Chest pain High blood pressure Swelling of the face, feet, or legs Skin irritation Changes in body weight Loss of appetite Change in taste Dark colored stools Headache Dizziness Vision changes Cough or runny nose Fever Allergic reaction Call your care team right away if your child has symptoms of an allergic reaction

However, impressive outcomes in clinical trials can fail to translate into sustained real-world success

In the S-LITE trial, people who added an exercise program while holding a big weight loss preserved their lean mass and improved their fitness, while the group on the drug alone did not (Lundgren et al., 2021)